Always check the BNF here for up-to-date prescribing advice.
- Thiazide-like diuretic with potent natriuretic effect.
- Typically used in combination with loop diuretics in resistant oedema.
- Short-term use is common due to risk of profound electrolyte disturbance.
⚙️ Mode of Action
- Blocks sodium reabsorption at the distal convoluted tubule (DCT), enhancing excretion of sodium, chloride, and water.
- Causes increased delivery of sodium to the distal nephron, promoting potassium and hydrogen ion excretion.
- Very potent in combination with loop diuretics due to synergistic action.
📋 Indications / Dose
- Congestive Cardiac Failure (CCF): Metolazone 2.5 mg OD (short-term, specialist supervision).
- Used for refractory oedema where loop diuretics alone are insufficient.
🔄 Interactions
- Caution with other diuretics ➝ ↑ risk of hypokalaemia, hyponatraemia, dehydration.
- Monitor electrolytes, renal function, and BP/HR closely.
- May potentiate lithium toxicity (reduced clearance).
⚠️ Cautions
- Diabetes mellitus (may worsen glycaemic control).
- Gout (may precipitate flares due to hyperuricaemia).
- Nephrotic syndrome.
- Systemic lupus erythematosus (SLE).
- Close monitoring of electrolytes, renal function, and fluid balance essential.
⛔ Contraindications
- See BNF for full list.
- Severe renal or hepatic impairment.
- Hypokalaemia, hyponatraemia, or hypovolaemia.
- Hypersensitivity to thiazides/thiazide-like diuretics.
⚡ Side Effects
- Electrolyte disturbances: ⬇️ sodium, potassium, magnesium; ⬆️ calcium, glucose, urate.
- Volume depletion ➝ hypotension, AKI, over-diuresis.
- Gout flares (due to raised uric acid).
- Metabolic alkalosis (low Cl⁻/HCO₃⁻ changes).
- Haematological: ↓ WCC, granulocytes, platelets (rare).
- Skin: Rashes, photosensitivity.
- Hepatic: Rare cholestasis.
- Pulmonary: Rare pneumonitis.
📚 References